Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  NeuBase Therapeutics, Inc.    NBSE

NEUBASE THERAPEUTICS, INC.

(NBSE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: September 2019 2020 2021 2022
Capitalization1 85,2199--
Entreprise Value (EV)1 85,2199199199
P/E ratio -1,53x-9,69x-8,81x-7,37x
Yield ----
Capitalization / Revenue ----
EV / Revenue ----
EV / EBITDA ----
Price to Book ----
Nbr of stocks (in thousands) 17 07023 122--
Reference price (USD) 4,998,628,628,62
Last update 01/09/2020---
1
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: September 2019 2020 2021 2022
Net sales1 ----
EBITDA ----
Operating profit (EBIT)1 -26,3-16,8-24,6-33,6
Operating Margin ----
Pre-Tax Profit (EBT)1 -27,0-17,3-24,4-33,6
Net income1 -27,0-17,3-24,4-33,6
Net margin ----
EPS2 -3,26-0,89-0,98-1,17
Dividend per Share ----
Last update 01/09/2020---
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: September 2019 2020 2021 2022
Net Debt ----
Net Cash position ----
Leverage (Debt / EBITDA) ----
Free Cash Flow1 -3,30-10,2-18,7-30,5
ROE (Net Profit / Equities) ----
Shareholders' equity1 ----
ROA (Net Profit / Asset) ----
Assets1 ----
Book Value Per Share ----
Cash Flow per Share ----
Capex1 0,460,680,961,24
Capex / Sales ----
Last update 01/09/202008/14/202008/14/202008/14/2020
1 USD in Million
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (USD)
199 314 682
Number of employees
15
Free-Float
78,0%
Free-Float capitalization (USD)
155 532 797
Avg. Exchange 20 sessions (USD)
1 475 218
Average Daily Capital Traded
0,74%
EPS & Dividend